SciBase enters into collaboration and license agreement with Castle Biosciences to develop diagnostic tests in dermatology and plans to carry out a directed issue of approximately SEK 30 million.
SciBase and Castle Biosciences Collaborate to Advance Dermatological Disease Treatments SciBase and Castle Biosciences have entered into a collaboration and licensing agreement to jointly explore and develop various clinical indications related to dermatological diseases. SciBase’s initial territory will encompass the EU, Switzerland, the United Arab Emirates, Japan, and South Korea, while Castle Biosciences will focus…